These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 31183519)
1. Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data. Garde C; Ramarathinam SH; Jappe EC; Nielsen M; Kringelum JV; Trolle T; Purcell AW Immunogenetics; 2019 Jul; 71(7):445-454. PubMed ID: 31183519 [TBL] [Abstract][Full Text] [Related]
2. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands. Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B Front Immunol; 2018; 9():1795. PubMed ID: 30127785 [TBL] [Abstract][Full Text] [Related]
3. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data. Reynisson B; Barra C; Kaabinejadian S; Hildebrand WH; Peters B; Nielsen M J Proteome Res; 2020 Jun; 19(6):2304-2315. PubMed ID: 32308001 [TBL] [Abstract][Full Text] [Related]
4. Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction. Wendorff M; Garcia Alvarez HM; Østerbye T; ElAbd H; Rosati E; Degenhardt F; Buus S; Franke A; Nielsen M Front Immunol; 2020; 11():1705. PubMed ID: 32903714 [TBL] [Abstract][Full Text] [Related]
5. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes. Zhao W; Sher X PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041 [TBL] [Abstract][Full Text] [Related]
6. NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions. Alvarez B; Reynisson B; Barra C; Buus S; Ternette N; Connelley T; Andreatta M; Nielsen M Mol Cell Proteomics; 2019 Dec; 18(12):2459-2477. PubMed ID: 31578220 [TBL] [Abstract][Full Text] [Related]
7. Footprints of antigen processing boost MHC class II natural ligand predictions. Barra C; Alvarez B; Paul S; Sette A; Peters B; Andreatta M; Buus S; Nielsen M Genome Med; 2018 Nov; 10(1):84. PubMed ID: 30446001 [TBL] [Abstract][Full Text] [Related]
8. Integral Use of Immunopeptidomics and Immunoinformatics for the Characterization of Antigen Presentation and Rational Identification of BoLA-DR-Presented Peptides and Epitopes. Fisch A; Reynisson B; Benedictus L; Nicastri A; Vasoya D; Morrison I; Buus S; Ferreira BR; Kinney Ferreira de Miranda Santos I; Ternette N; Connelley T; Nielsen M J Immunol; 2021 May; 206(10):2489-2497. PubMed ID: 33789985 [TBL] [Abstract][Full Text] [Related]
9. Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Andreatta M; Karosiene E; Rasmussen M; Stryhn A; Buus S; Nielsen M Immunogenetics; 2015 Nov; 67(11-12):641-50. PubMed ID: 26416257 [TBL] [Abstract][Full Text] [Related]
10. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Reynisson B; Alvarez B; Paul S; Peters B; Nielsen M Nucleic Acids Res; 2020 Jul; 48(W1):W449-W454. PubMed ID: 32406916 [TBL] [Abstract][Full Text] [Related]
11. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. Nielsen M; Lundegaard C; Lund O BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956 [TBL] [Abstract][Full Text] [Related]
12. Improved methods for predicting peptide binding affinity to MHC class II molecules. Jensen KK; Andreatta M; Marcatili P; Buus S; Greenbaum JA; Yan Z; Sette A; Peters B; Nielsen M Immunology; 2018 Jul; 154(3):394-406. PubMed ID: 29315598 [TBL] [Abstract][Full Text] [Related]
13. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships. Hattotuwagama CK; Doytchinova IA; Flower DR Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004 [TBL] [Abstract][Full Text] [Related]
14. Predicted MHC peptide binding promiscuity explains MHC class I 'hotspots' of antigen presentation defined by mass spectrometry eluted ligand data. Jappe EC; Kringelum J; Trolle T; Nielsen M Immunology; 2018 Jul; 154(3):407-417. PubMed ID: 29446062 [TBL] [Abstract][Full Text] [Related]
15. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes. Jørgensen KW; Buus S; Nielsen M PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859 [TBL] [Abstract][Full Text] [Related]
16. NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data. Jurtz V; Paul S; Andreatta M; Marcatili P; Peters B; Nielsen M J Immunol; 2017 Nov; 199(9):3360-3368. PubMed ID: 28978689 [TBL] [Abstract][Full Text] [Related]
17. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy. Mitić NS; Pavlović MD; Jandrlić DR J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036 [TBL] [Abstract][Full Text] [Related]
18. NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets. Nielsen M; Andreatta M Genome Med; 2016 Mar; 8(1):33. PubMed ID: 27029192 [TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of peptide-MHC class II interaction. Fleckenstein B; Jung G; Wiesmüller KH Semin Immunol; 1999 Dec; 11(6):405-16. PubMed ID: 10625594 [TBL] [Abstract][Full Text] [Related]
20. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]